Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals

Details for Australian Patent Application No. 2006264051 (hide)

Owner Sanofi-Aventis

Inventors Strobel, Hartmut; Wohlfart, Paulus; Will, David William; Zoller, Gerhard

Agent Watermark

Pub. Number AU-B-2006264051

PCT Pub. Number WO2007/000248

Priority 05013869.2 28.06.05 EP

Filing date 14 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 19 January 2012

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/000248 Priority application(s): WO2007/000248

19 January 2012 Application Accepted

  Published as AU-B-2006264051

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006264057-Pigments

2006264049-Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals